Tag: COVID-19

The UNC Institute for Global Health and Infectious Diseases is now enrolling participants in a fast-track trial of an oral COVID-19 treatment known as Bemnifosbuvir (BEM). Currently, Paxlovid is used for treating COVID-19. However, it is known to interact with common drugs that treat cholesterol, blood clots, and other conditions....

A student research team led by Victor Arahirwa, a 2024 MD Candidate, received the Harold C. Pillsbury, MD Student Research Award for Excellent Poster Presentation (Clinical Science) during the recent John B. Graham Medical Student Research Society’s Annual Student Research Day. From 2004 to 2016, the Centers for Disease Prevention and...

UNC’s Institute of Global Health and Infectious Diseases Director Myron Cohen, MD, is the lead investigator of a study recently published in the Journal of the American Medical Association (JAMA) that shows bamlanivimab monotherapy reduced the incidence of infection in skilled nursing homes and assisted living facilities with high risk of SARS-CoV-2 exposure. The...

Ross Boyce, MD, MSc Assistant Professor of Medicine, UNC Infectious Diseases Allison Aiello, PhD Professor of Epidemiology, UNC Gillings School of Global Public Health    After service with the U.S. Army that included two deployments to Iraq in a variety of leadership positions and earning three Bronze Star Medals, Ross...

Presented by David Wohl, MD, professor of medicine, UNC Division of Infectious Diseases Wohl is site leader of UNC’s Global Infectious Diseases Clinical Research Group at Chapel Hill. For the past year, during the COVID-19 pandemic, Wohl has been serving as medical director of the COVID-19 vaccination clinics at UNC...

Presented by Larry Corey, MD Past President and Director, Professor of Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center Professor, Medicine and Laboratory Medicine, University of Washington Corey is an internationally renowned expert in virology, immunology and vaccine development. His research focuses on herpes viruses, HIV, the novel...

Heidi J. Larson, MA, PhD, is an anthropologist and director of The Vaccine Confidence Project; professor of anthropology, risk and decision science in the Department of Infectious Disease Epidemiology at London School of Hygiene and Tropical Medicine; clinical professor in the Department of Global Health at University of Washington; and guest...

In February 2020, as bits of data about the SARS-CoV-2 virus started to emerge, Cindy Gay, MD, MPH, and UNC infectious diseases colleagues began meeting to formulate a local response to the virus. They’ve met weekly ever since, resorting to Zoom calls once the university sent employees home in March....

The National Institutes of Health has awarded Myron Cohen, MD, director of UNC’s Institute for Global Health and Infectious Diseases, and FHI 360 $9.2 million to support research through the new COVID Prevention Network (CoVPN). The National Institute of Allergy and Infectious Diseases at the National Institutes of Health has...

By the spring of 2020, the urgency of the COVID-19 pandemic caused many researchers affiliated with UNC’s Institute for Global Health and Infectious Diseases to pivot their studies to focus on testing, treatment and prevention of the SARS-CoV-2 virus. Here, a look at some of the projects underway in the...

Ross Boyce, MD, MSc, assistant professor of medicine in the infectious diseases division, and, Allison Aiello, PhD, MS, professor of epidemiology at the UNC Gillings School of Global Public Health, are leading a study along with Aaron Fleischauer, PhD, MSPH, at NC Department of Health and Human Services and other...

By Alyssa LaFaro As seven states now require masks and face coverings for visiting essential businesses or using public transportation, it seems like those spaces are where we are most at risk for COVID-19 infection. But, in truth, the riskiest place could be our homes — at least, if you live with someone...

Irving Hoffman, international director of the Institute’s UNC Project-Malawi, offers this report as the country recorded its first death from COVID-19. As of April 8, 2020, despite limited testing, Malawi has recorded 10 COVID-19 cases with one death and some evidence of community spread. UNC Project-Malawi is taking a leading...

Linghua Li, MD, PhD, is an infectious disease specialist and AIDS clinic director at Eighth People’s Hospital in Guangzhou, China. She did two years of postdoctoral training in infectious diseases at Duke University and at UNC, working with the Institute’s David Wohl, MD. Here, she reports from the frontlines on dealing with COVID-19 in Guangzhou, which...